Envision Pharma Group is expanding its Envision the Patient team with the appointment of Amanda Boughey, who joins from Cancer Research UK. Amanda joins the award winning team as its new Global ...
The US government has announced the ten drugs selected for the first round of pricing negotiations under President Biden’s Inflation Reduction Act (IRA). The IRA allows Medicare, the government health ...
An international study has identified 11 new gene alterations connected to more aggressive prostate cancer using a simple blood test. The discovery could improve treatments for prostate cancer by ...
A group of scientists from the University of Surrey have shared findings from a seven-year research study, revealing that a new approach could be on the horizon for treating one of the most prevalent ...
A wide range of top-performing healthcare comms agencies, charities and healthcare communicators claimed the honours at last night’s annual Communiqué Awards. The awards, run every year by PMLive’s ...
Shire is considering a move to acquire Swiss biopharma company Actelion in a move that would boost its rare disease portfolio. According to a report in the Sunday Times, Shire made an informal ...
Pfizer and Clear Creek Bio have announced a collaboration aiming to advance the discovery and development of novel papain-like protease (PLpro) inhibitors and potentially introduce a new class of oral ...
BioNTech has announced it will acquire UK AI start-up InstaDeep in a deal worth up to £562m, following the company’s initial equity investment as part of InstaDeep’s Series B financing round in ...
Merck & Co is closing on a new indication for its checkpoint inhibitor Keytruda in early bladder cancer in the US, following a positive vote by an FDA expert panel. The Oncologic Drugs Advisory ...
This year, due to the COVID-19 pandemic and social distancing requirements, the PMEA Awards event will be streamed live at pmlive.com/pmea2020. After receiving a high ...
French pharma company Servier and biopharma company Oncodesign have reach the first milestone in their collaboration on research and development into new drug candidates for Parkinson’s disease. In a ...
Global communications firm Edelman has announced the appointment of Jenni Mercer as UK head of healthcare marketing. Mercer has over two decades of experience in integrated healthcare marketing across ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback